Centene Corporation (CNC)
- Previous Close
75.61 - Open
75.90 - Bid 75.09 x 800
- Ask 75.46 x 1000
- Day's Range
75.05 - 76.08 - 52 Week Range
63.45 - 81.42 - Volume
3,773,872 - Avg. Volume
4,003,522 - Market Cap (intraday)
39.636B - Beta (5Y Monthly) 0.48
- PE Ratio (TTM)
14.19 - EPS (TTM)
5.31 - Earnings Date Oct 25, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
86.07
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.
www.centene.comRecent News: CNC
View MorePerformance Overview: CNC
Trailing total returns as of 9/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CNC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CNC
View MoreValuation Measures
Market Cap
39.77B
Enterprise Value
37.19B
Trailing P/E
14.24
Forward P/E
10.11
PEG Ratio (5yr expected)
0.71
Price/Sales (ttm)
0.26
Price/Book (mrq)
1.45
Enterprise Value/Revenue
0.24
Enterprise Value/EBITDA
6.46
Financial Highlights
Profitability and Income Statement
Profit Margin
1.96%
Return on Assets (ttm)
3.78%
Return on Equity (ttm)
10.59%
Revenue (ttm)
144.06B
Net Income Avi to Common (ttm)
2.82B
Diluted EPS (ttm)
5.31
Balance Sheet and Cash Flow
Total Cash (mrq)
20.21B
Total Debt/Equity (mrq)
64.20%
Levered Free Cash Flow (ttm)
1.97B